Little is known about the effect of combination antiretroviral therapy (cART) on life expectancy in sub-Saharan Africa

Bakanda, Celestin

Birungi, Josephine

Chan, Keith

Cooper, Curtis L

Dybul, Mark

Ford, Nathan

Hogg, Robert S

Mills, Edward J

Nachega, Jean B

English

MSF Field Research

British Columbia Centre for Excellence

Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

Evaluation of methodologies for small area life expectancy estimation. J Epidemiol Community Health.

late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med.

Mc´decins Sans Frontie`res, Rue de Lausanne, Building 78-CP 116-1211,

Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in

Namale A. Uganda Ministry of Health. National Antiretroviral Treatment Guidelines for Adults, Adolescents, and Children. 3rd ed.

On constructing current life tables.

Original Research Life Expectancy of Persons Receiving Antiretroviral Therapy in Uganda 216 16

Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naı¨ve individuals in a Western setting. HIV Med.

Recommendations for a public health approach. Accessed at www.who.int/hiv /pub/guidelines/adult/en/index.htmlon 27

Samplingbased approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa [Letter].

Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda. PLoS One.

The Life Table and Its Construction. Introduction to Stochastic Processes in Biostatistics.

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda

This study was little known about the effect of combination antiretroviral therapy (cART) on life expectancy in sub-Saharan Africa.Background: Little is known about the effect of combination antiretroviral therapy (cART) on life expectancy in sub-Saharan Africa.
Objective: To estimate life expectancy of patients once they initiate cART in Uganda.
Design: Prospective cohort study.
Setting: Public sector HIV and AIDS disease-management program in Uganda.
Patients: 22 315 eligible patients initiated cART during the study period, of whom 1943 were considered to have died.
Measurements: All-cause mortality rates were calculated and abridged life tables were constructed and stratified by sex and baseline CD4 cell count status to estimate life expectancies for patients receiving cART. The average number of years remaining to be lived by patients who received cART at varying age categories was estimated.
Results: After adjustment for loss to follow-up, crude mortality rates (deaths per 1000 person-years) ranged from 26.9 (95% CI, 25.4 to 28.5) in women to 43.9 (CI, 40.7 to 47.0) in men. For patients with a baseline CD4 cell count less than 0.050 _ 109 cells/L, the mortality rate was 67.3 (CI, 62.1 to 72.9) deaths per
1000 person-years, whereas among persons with a baseline CD4 cell count of 0.250 _ 109 cells/L or more, the mortality rate was
19.1 (CI, 16.0 to 22.7) deaths per 1000 person-years. Life expectancy at age 20 years for the overall cohort was 26.7 (CI, 25.0 to 28.4) additional years and at age 35 years was 27.9 (CI, 26.7 to 29.1) additional years. Life expectancy increased substantially with increasing baseline CD4 cell count. Similar trends are observed for older age groups.
Limitations: A small (6.4%) proportion of patients were lost to follow-up, and it was imputed that 30% of these patients had died.
Few patients with a CD4 cell count greater than 0.250 _ 109 cells/L initiated cART.
Conclusion: Ugandan patients receiving cART can expect an almost normal life expectancy, although there is considerable variability among subgroups of patients

Mills, Edward J.

Cooper, Curtis L.

Nachega, Jean B.

Hogg, Robert S.

Uganda Christian University Digital Institutional Repository

Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis from Uganda

Edward J. Mills

Celestin Bakanda

Josephine Birungi

Keith Chan

Nathan Ford

Curtis L. Cooper

Jean B. Nachega

Mark Dybul

Robert S. Hogg

Crossref

Annals of Internal Medicine

Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda

Abstract

Similar works

Full text

Available Versions

MSF Field Research

Uganda Christian University Digital Institutional Repository

Crossref